CoChat

In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls

Open access

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Individuals with narcolepsy suffer from abnormal sleep patterns due to loss of neurons that uniquely supply hypocretin (HCRT). Previous studies found associations of narcolepsy with the human leukocyte antigen (HLA)-DQ6 allele and T-cell receptor α (TRA) J24 gene segment and also suggested that in vitro-stimulated T cells can target HCRT. Here, we present evidence of in vivo expansion of DQ6-HCRT tetramer+/TRAJ24+/CD4+ T cells in DQ6+ individuals with and without narcolepsy. We identify related TRAJ24+ TCRαβ clonotypes encoded by identical α/β gene regions from two patients and two controls. TRAJ24-G allele+ clonotypes only expand in the two patients, whereas a TRAJ24-C allele+ clonotype expands in a control. A representative tetramer+/G-allele+ TCR shows signaling reactivity to the epitope HCRT 87–97. Clonally expanded G-allele+ T cells exhibit an unconventional effector phenotype. Our analysis of in vivo expansion of HCRT-reactive TRAJ24+ cells opens an avenue for further investigation of the autoimmune contribution to narcolepsy development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-13234-x

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic illustration of approach. a An array of overlapping peptides covering the entire candidate autoantigen HCRT is tested for HLA-DQ6 binding. b DQ6-HCRTpeptide tetramers are synthesized based on the DQ6-binding cores determined in a. c Ex vivo CD4+ T cells are isolated from PBMCs of DQ6+ patients and controls using negative selection by magnetic-activated cell sorting (MACS); purified CD4+ T cells are co-stained with candidate tetramers and antibodies distinguishing cell types (i.e., anti-CD4, anti-CD19). DQ6-HCRTpeptide tetramer+/CD4+ cells are sorted by single cell index sorting (iFACS). Given the discordance between tetramer positivity and true autoreactivity, the iFACS-sorted cells likely include tetramer+ clones with various tetramer-binding ranks, clone size, and disease-relevance: T1N-relevant (darker clones expressing public/related TCRs or unique/private TCRs) or irrelevant (lighter clones); expansion is indicated using doublets. Clones expressing TCR risk gene alleles may also be observed in DQ6+ controls, as DQ6-restricted selection may occur similarly in patients and controls and T1N development is thought to rely largely on antigen-driven clonal expansion. d Deep sequencing of TCR and phenotypic transcripts in sorted single cells allows further assessment of T1N-associated gene signatures of tetramer+ clones including both in vivo clonal expansion and expression of the TCR risk gene. e–h The DQ6-restricted TCR sequences are validated for ability to generate an expressed α/β TCR that binds relevant tetramers and signals after stimulation with relevant peptide epitopes. The first author created this figure
Fig. 1 Schematic illustration of approach. a An array of overlapping peptides covering the entire candidate autoantigen HCRT is tested for HLA-DQ6 binding. b DQ6-HCRTpeptide tetramers are synthesized based on the DQ6-binding cores determined in a. c Ex vivo CD4+ T cells are isolated from PBMCs of DQ6+ patients and controls using negative selection by magnetic-activated cell sorting (MACS); purified CD4+ T cells are co-stained with candidate tetramers and antibodies distinguishing cell types (i.e., anti-CD4, anti-CD19). DQ6-HCRTpeptide tetramer+/CD4+ cells are sorted by single cell index sorting (iFACS). Given the discordance between tetramer positivity and true autoreactivity, the iFACS-sorted cells likely include tetramer+ clones with various tetramer-binding ranks, clone size, and disease-relevance: T1N-relevant (darker clones expressing public/related TCRs or unique/private TCRs) or irrelevant (lighter clones); expansion is indicated using doublets. Clones expressing TCR risk gene alleles may also be observed in DQ6+ controls, as DQ6-restricted selection may occur similarly in patients and controls and T1N development is thought to rely largely on antigen-driven clonal expansion. d Deep sequencing of TCR and phenotypic transcripts in sorted single cells allows further assessment of T1N-associated gene signatures of tetramer+ clones including both in vivo clonal expansion and expression of the TCR risk gene. e–h The DQ6-restricted TCR sequences are validated for ability to generate an expressed α/β TCR that binds relevant tetramers and signals after stimulation with relevant peptide epitopes. The first author created this figureCC BY · PubMed Central
Fig. 2 DQ6-binding cores in prepro-HCRT and their structural impacts. a Thirty overlapping peptides covering prepro-HCRT were added, individually, into a reaction containing soluble DQ6, bio-EBV486–500 peptide, and HLA-DM (a peptide loading catalyst). DQ6-associated bio-EBV486–500 was measured at steady state by ELISA31. %Competition = 1−%DQ6/EBV binding. Strong (>75%Competition, in colors) and weak (50–75%Competition, in gray) DQ6 binders with predicted cores (bolded) are aligned. Data are represented as mean ± SEM (standard error of the mean); n = 4. b Top view of HCRT56–69 (orange) in the peptide-binding groove of DQ6 (α/β, light green/blue surface, PDB: 6DIG). Core residues are indicated. c Alignment of DQ6-HCRT56–69 (α/β, light green/blue cartoon; peptide, orange stick) and DQ6-HCRT1–13 structures34 (α/β, dark green/blue; peptide, magenta) illustrating three regions in DQ6 with noticeable conformation differences (detailed in Supplementary Fig. 1e). d Side view of DQ6 (β chain removed to reveal peptides) in complex with HCRT1–13 (PDB: 1UVQ) and DQ6-HCRT56–69 (PDB: 6DIG) and models of HCRT25–37 and HCRT87–100 (sticks in the same color as in a). Arrow indicates predicted positioning for interaction of TCRα/β CDR3s. e Zoom-in of the 9-aa core registers of peptides shown in d. Arrows indicate TCR (up) or DQ6 (down) facing resides
Fig. 2 DQ6-binding cores in prepro-HCRT and their structural impacts. a Thirty overlapping peptides covering prepro-HCRT were added, individually, into a reaction containing soluble DQ6, bio-EBV486–500 peptide, and HLA-DM (a peptide loading catalyst). DQ6-associated bio-EBV486–500 was measured at steady state by ELISA31. %Competition = 1−%DQ6/EBV binding. Strong (>75%Competition, in colors) and weak (50–75%Competition, in gray) DQ6 binders with predicted cores (bolded) are aligned. Data are represented as mean ± SEM (standard error of the mean); n = 4. b Top view of HCRT56–69 (orange) in the peptide-binding groove of DQ6 (α/β, light green/blue surface, PDB: 6DIG). Core residues are indicated. c Alignment of DQ6-HCRT56–69 (α/β, light green/blue cartoon; peptide, orange stick) and DQ6-HCRT1–13 structures34 (α/β, dark green/blue; peptide, magenta) illustrating three regions in DQ6 with noticeable conformation differences (detailed in Supplementary Fig. 1e). d Side view of DQ6 (β chain removed to reveal peptides) in complex with HCRT1–13 (PDB: 1UVQ) and DQ6-HCRT56–69 (PDB: 6DIG) and models of HCRT25–37 and HCRT87–100 (sticks in the same color as in a). Arrow indicates predicted positioning for interaction of TCRα/β CDR3s. e Zoom-in of the 9-aa core registers of peptides shown in d. Arrows indicate TCR (up) or DQ6 (down) facing residesCC BY · PubMed Central
Fig. 3 Tetramer+/CD4+ T cells in DQ6+ donors. a Dot-plots of CD4+ T cells stimulated in vitro with the indicated peptides followed by staining with the indicated tetramers. Frequencies (%) of tetramer+/CD4+ T cells are indicated. b Comparison between frequencies of tetramer+ T cells from the same T1N donor (paired as indicated) with and without peptide stimulation. Significance (P < 0.05, bolded) is determined using the paired samples t-test (n = 13 donors). c Enrichment (with peptide stimulation vs. without) of DQ6-HCRT56–69 tetramer+/CD4+ T cells in HCRT87–100 peptide stimulated culture. d Frequencies or e tetramer-binding ranks (mean index fluorescence intensity) of tetramer+ T cells from patients and controls (sample information summarized in Table 1) stained with the indicated tetramers. Statistical analysis compares control and patient samples within each tetramer specificity. Significance (P < 0.05, bolded) is determined using the unequal variance t-test. The error bar represents mean ± SEM
Fig. 3 Tetramer+/CD4+ T cells in DQ6+ donors. a Dot-plots of CD4+ T cells stimulated in vitro with the indicated peptides followed by staining with the indicated tetramers. Frequencies (%) of tetramer+/CD4+ T cells are indicated. b Comparison between frequencies of tetramer+ T cells from the same T1N donor (paired as indicated) with and without peptide stimulation. Significance (P < 0.05, bolded) is determined using the paired samples t-test (n = 13 donors). c Enrichment (with peptide stimulation vs. without) of DQ6-HCRT56–69 tetramer+/CD4+ T cells in HCRT87–100 peptide stimulated culture. d Frequencies or e tetramer-binding ranks (mean index fluorescence intensity) of tetramer+ T cells from patients and controls (sample information summarized in Table 1) stained with the indicated tetramers. Statistical analysis compares control and patient samples within each tetramer specificity. Significance (P < 0.05, bolded) is determined using the unequal variance t-test. The error bar represents mean ± SEMCC BY · PubMed Central
Fig. 4 Public features of clonotypes with more than one isolate from our dataset. a A heat map illustrating 9 groups (I–IX) of cells from multiple subjects sharing identical paired TRBJ/TRAJ genes. Number of isolates of the same clonotype is proportional to the color intensity. Tetramer specificity is differentiated by colors. Tetramer categories without any hit on the heat map are not shown. b Frequencies of V or J genes used in 57 TCRα/β clonotypes with multiple isolates compared with “All Wells” that return sequences (see Supplementary Data 2) or “All Cells” with productive α/β CDR3 sequences (see Supplementary Data 3). Arrows indicate genes used in TRBV29–1_TRBJ2-5/TRAV6_TRAJ24-expressing cells, with fold increase compared to “All Cells”
Fig. 4 Public features of clonotypes with more than one isolate from our dataset. a A heat map illustrating 9 groups (I–IX) of cells from multiple subjects sharing identical paired TRBJ/TRAJ genes. Number of isolates of the same clonotype is proportional to the color intensity. Tetramer specificity is differentiated by colors. Tetramer categories without any hit on the heat map are not shown. b Frequencies of V or J genes used in 57 TCRα/β clonotypes with multiple isolates compared with “All Wells” that return sequences (see Supplementary Data 2) or “All Cells” with productive α/β CDR3 sequences (see Supplementary Data 3). Arrows indicate genes used in TRBV29–1_TRBJ2-5/TRAV6_TRAJ24-expressing cells, with fold increase compared to “All Cells”CC BY · PubMed Central
Fig. 5 Public features of the eTRAJ24 clonotypes. a Analysis of CDR3 motifs shared by groups of TCRβ (left) or TCRα (right) by GLIPH algorithm24. Each dot represents one motif: global (red), local (blue), and single (gray) (see Supplementary Data 4 for definitions). 25 CDR3β motifs and 16 CDR3α motifs reach significance (P < 0.05, the upper right quadrant) when analyzed for enrichment of V genes and expanded clones compared to a reference dataset as described24. The α/β motifs used in eTRAJ24 clonotypes (shown in red to the right of each plot) have the highest overall significance. The radius of dots reflects the final score (see details in Supplementary Data 4). b Number of subjects with clonotypes using paired α/β motifs from the 25 β and 16 α motifs. Motifs are color-coded as in a. #clonotype with #isolates from the indicated donor(s) is also shown on the heatmap or summarized in c. c Summary of tetramer-identified clones expressing TRBV29-1_TRBJ2-5/TRAV6_TRAJ24 genes. The L residue of the G (SNP) allele is indicated in red. The three eTRAJ24L clonotypes are shaded. The CDR3 sequences using E%DRGRSET and/or %TDSWGK motifs are bolded. d Tetramer binding rank of individual eTRAJ24L+ cells. Bar graphs represent the mean ± SEM FI of all sorted CD4+/tetramer+ single cells from the indicated subject-tetramer category. Open symbols are for only eTRAJ24L+ cells within the same subject-tetramer category, as in the corresponding bar graph. All values are normalized with background MFI of the entire CD4+ population in the tetramer detection channel
Fig. 5 Public features of the eTRAJ24 clonotypes. a Analysis of CDR3 motifs shared by groups of TCRβ (left) or TCRα (right) by GLIPH algorithm24. Each dot represents one motif: global (red), local (blue), and single (gray) (see Supplementary Data 4 for definitions). 25 CDR3β motifs and 16 CDR3α motifs reach significance (P < 0.05, the upper right quadrant) when analyzed for enrichment of V genes and expanded clones compared to a reference dataset as described24. The α/β motifs used in eTRAJ24 clonotypes (shown in red to the right of each plot) have the highest overall significance. The radius of dots reflects the final score (see details in Supplementary Data 4). b Number of subjects with clonotypes using paired α/β motifs from the 25 β and 16 α motifs. Motifs are color-coded as in a. #clonotype with #isolates from the indicated donor(s) is also shown on the heatmap or summarized in c. c Summary of tetramer-identified clones expressing TRBV29-1_TRBJ2-5/TRAV6_TRAJ24 genes. The L residue of the G (SNP) allele is indicated in red. The three eTRAJ24L clonotypes are shaded. The CDR3 sequences using E%DRGRSET and/or %TDSWGK motifs are bolded. d Tetramer binding rank of individual eTRAJ24L+ cells. Bar graphs represent the mean ± SEM FI of all sorted CD4+/tetramer+ single cells from the indicated subject-tetramer category. Open symbols are for only eTRAJ24L+ cells within the same subject-tetramer category, as in the corresponding bar graph. All values are normalized with background MFI of the entire CD4+ population in the tetramer detection channelCC BY · PubMed Central
Fig. 6 Validation of tetramer binding and TCR signaling. a TCRs tested by transfection into Jurkat-luciferase reporter system24. b Dot-plots of Jurkat transfectants expressing TCRs as shown in a. Expression of GFP indicates a successful transfection of plasmids directing the expression of TCRs. c Tetramer staining of TCR+ Jurkat cells with percentages of tetramer+ cells indicated. d MFIs of the tetramer-associated signal on the surface of TCR+ cells are compared. e Jurkat cells expressing the indicated TCR were incubated with DQ6-expressing APCs (HLA class II- K562 cells transfected with DQ6) in the presence of HCRT peptides or control stimuli: PBS (negative) or anti-CD3/anti-CD28 Abs (positive). Luciferase activity reflecting TCR-mediated signaling was measured and analyzed as previously described24. The bar chart shows mean ± SEM, with the corresponding data points overlaid. Significance (P < 0.05, bolded) is determined using t-test comparing the indicated TCR and the TCR control
Fig. 6 Validation of tetramer binding and TCR signaling. a TCRs tested by transfection into Jurkat-luciferase reporter system24. b Dot-plots of Jurkat transfectants expressing TCRs as shown in a. Expression of GFP indicates a successful transfection of plasmids directing the expression of TCRs. c Tetramer staining of TCR+ Jurkat cells with percentages of tetramer+ cells indicated. d MFIs of the tetramer-associated signal on the surface of TCR+ cells are compared. e Jurkat cells expressing the indicated TCR were incubated with DQ6-expressing APCs (HLA class II- K562 cells transfected with DQ6) in the presence of HCRT peptides or control stimuli: PBS (negative) or anti-CD3/anti-CD28 Abs (positive). Luciferase activity reflecting TCR-mediated signaling was measured and analyzed as previously described24. The bar chart shows mean ± SEM, with the corresponding data points overlaid. Significance (P < 0.05, bolded) is determined using t-test comparing the indicated TCR and the TCR controlCC BY · PubMed Central
Fig. 7 Phenotypic features of tetramer+/CD4+ cells expressing the TRAJ24 gene. a Sequenced cells from controls (C) or patients (P) in each set (Table 1) are clustered as indicated. Each color in the horizontal bar above the heat map represents one donor. Red indicates the presence of mRNA in the cell. Genes to the left of the heat map are grouped according to their usage in different conventional T cell subsets23. *Different sets of primers were used to amplify IFN-γ mRNAs in cells from Set A and Set B donors. b Frequencies of expanded versus unexpanded cells expressing the indicated transcript. c Phenotypes of expanded or unexpanded TRAJ24L+ clones versus TRAJ24F+ clones. Each color in the horizontal bar represents one subject-tetramer category of single cells. Patients (P) or controls (C) are clustered as indicated. The expanded TRAJ24L (red font) cluster includes the unexpanded clonotype from P3, as it only differs from other eTRAJ24L clonotypes from the same patient by 1 residue in both α/β CDR3 sequences. d Frequencies of cells from the indicated cluster expressing the indicated transcript in c. The scale of color intensity is the same as in b
Fig. 7 Phenotypic features of tetramer+/CD4+ cells expressing the TRAJ24 gene. a Sequenced cells from controls (C) or patients (P) in each set (Table 1) are clustered as indicated. Each color in the horizontal bar above the heat map represents one donor. Red indicates the presence of mRNA in the cell. Genes to the left of the heat map are grouped according to their usage in different conventional T cell subsets23. *Different sets of primers were used to amplify IFN-γ mRNAs in cells from Set A and Set B donors. b Frequencies of expanded versus unexpanded cells expressing the indicated transcript. c Phenotypes of expanded or unexpanded TRAJ24L+ clones versus TRAJ24F+ clones. Each color in the horizontal bar represents one subject-tetramer category of single cells. Patients (P) or controls (C) are clustered as indicated. The expanded TRAJ24L (red font) cluster includes the unexpanded clonotype from P3, as it only differs from other eTRAJ24L clonotypes from the same patient by 1 residue in both α/β CDR3 sequences. d Frequencies of cells from the indicated cluster expressing the indicated transcript in c. The scale of color intensity is the same as in bCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

See all 58

Metadata

Authors
Jiang, W., Birtley, J. R., Hung, S.-C., Wang, W., Chiou, S.-H., Macaubas, C., Kornum, B., Tian, L., Huang, H., Adler, L., Weaver, G., Lu, L., Ilstad-Minnihan, A., Somasundaram, S., Ayyangar, S., Davis, M. M., Stern, L. J., & Mellins, E. D.
Affiliations
  • Stanford Medicine (US)
  • University of Massachusetts Chan Medical School (US)
  • Glostrup Hospital (DK)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Jiang, Wei
  • Mellins, Elizabeth D.
Venue
Nature Communications
Published
2019-11-20
Volume
10
Issue
1
Pages
5247-5247
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2989925705
Cited by
58
References
57
Citations by year
2026: 3 · 2025: 12 · 2024: 5 · 2023: 6 · 2022: 13 · 2021: 14 · 2020: 4
FWCI
4.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • eScholarship@UMassChan (submittedVersion, cc-by)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • GlaoSmithKline Biologicals SA
  • The Child Health Research Institute, Lucile Packard Foundation for Children’s Health, as well as the Stanford CTSA
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
narcolepsy, orexin, CD4+ T cells, clonal expansion, HLA-DQ6, T cell receptor alpha chain, tetramer analysis, autoimmune T cells, hypocretin neurons
MeSH terms
Orexins, Animals, Drosophila, HLA-DQ Antigens, Humans, Immunoglobulin Joining Region, Narcolepsy, Phenotype, CD4-Positive T-Lymphocytes, Autoimmunity, Case-Control Studies, Receptors, Antigen, T-Cell, alpha-beta, Crystallography, X-Ray, Cell Proliferation, Peripheral Tolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls. https://app.cochat.ai/papers/10.1038/s41467-019-13234-x
The paper
Jiang, W., Birtley, J. R., Hung, S.-C., Wang, W., Chiou, S.-H., Macaubas, C., Kornum, B., Tian, L., Huang, H., Adler, L., Weaver, G., Lu, L., Ilstad-Minnihan, A., Somasundaram, S., Ayyangar, S., Davis, M. M., Stern, L. J., & Mellins, E. D. (2019). In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls. Nature Communications. https://doi.org/10.1038/s41467-019-13234-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.